Search

Search Constraints

You searched for: Author/Creator Stenvang, Jan

Search Results

1. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. Issue 1 (December 2016)

2. Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. Issue 1 (December 2016)

3. Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance. Issue 1 (December 2017)

5. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance. Issue 6 (24th February 2015)

6. Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO‐101 in adult male and female volunteers. Issue 4 (23rd July 2020)

7. High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer. Issue 3 (28th February 2013)

9. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Issue 1 (25th September 2015)

10. Metallopeptidase inhibitor 1 (TIMP‐1) promotes receptor tyrosine kinase c‐Kit signaling in colorectal cancer. Issue 12 (24th October 2019)